At the PM Society Digital Interest Group (DIG), we set out to explore the role of AI in pharma marketing—not just by discussing it but by using AI to help write the very articles we were producing. This was far more than a writing exercise; it was an experiment in collaboration between human expertise and machine intelligence.
The Pharmaceutical Marketing Impact and Innovation (PMi) Awards, celebrating impact and innovation in pharmaceutical marketing and healthcare communications, launch on…
21GRAMS and Havas Lynx win big AstraZeneca and UCB top client leader board The 39th PM Society Awards, supported by…
The PM Society Diversity Interest Group have dived into the 2024 diversity survey results showing that ageism is still being experienced in our industry.
The PM Society Digital Interest Group are pleased to share an article that challenges how effective our industries approach is to marketing.
Artificial intelligence is reshaping the pharmaceutical industry, offering powerful solutions to improve marketing, medical affairs, and operations. This article provides actionable insights for pharmaceutical professionals, through real-life examples.
The Industry Agency Relationships Interest Group has been working on a guide to procurement in pharma marketing and communications for over a year.
As 2024 draws to a close, it’s a great opportunity to reflect on our great work and achievements over the year.
In 2021 the PM Society Diversity & Inclusion Interest Group decided to explore experiences of diversity and inclusion in pharma and healthcare agency organisations. The survey gave some valuable insights and brought up some interesting questions and the group decided to repeat the survey in 2024. The results have been compared to see how the situation has changed in the last 3 years.
Great session with Simon Lloyd hearing lessons in marketing leadership from other sectors.
